Showing posts with label palmer. Show all posts
Showing posts with label palmer. Show all posts

Sunday 29 January 2017

Cryoneedles A Possible Alternative To Botox In Fighting Against Wrinkles

Cryoneedles A Possible Alternative To Botox In Fighting Against Wrinkles.
A altered technology that fleetingly zaps away forehead wrinkles by freezing the nerves shows commitment in early clinical trials, researchers say. The technique, if at the end of the day approved by the US Food and Drug Administration, could provide an alternative to Botox and Dysport. Both are injectable forms of Botulinum toxin group A, a neurotoxin that, when injected in slight quantities, temporarily paralyzes facial muscles, thereby reducing wrinkles example. "It's a toxin-free alternate to treating unwanted lines and wrinkles, similar to what is being done with Botox and Dysport," said contemplate co-author Francis Palmer, director of facial plastic surgery at the University of Southern California School of Medicine in Los Angeles.

And "From the inappropriate clinical trials, this procedure - which its maker calls cryoneuromodulation - appears to have the same clinical efficacy and shelter comparable to the existing techniques". Palmer is also consulting medical overseer of MyoScience Inc, the Redwood City (California) - based firm developing the cryotechnology saheli. The results of the clinical trials were to be presented Friday at an American Society for Laser Medicine and Surgery (ASLMS) talk in Grapevine, Texas.

To do the procedure, physicians use meagre needles - "cryoprobes" - to deliver cold to nerves continual through the forehead, specifically the temporal branch of the frontal nerve. The cold freezes the nerve, which interrupts the resoluteness signal and relaxes the muscle that causes vertical and horizontal forehead lines. Although the grit quickly returns to normal body temperature, the cold temporarily "injures" the nerve, allowing the unusual to remain interrupted for some period of time after the patient leaves the office.

The modus operandi does not permanently damage the nerve. Researchers said they are still refining the technique and could not say how large the effect lasts, but it seems to be comparable to Botox, which works for about three to four months. Physicians would necessary training to identify the nerve that should be targeted.